Identification of novel and rare CYP21A2 variants in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:1
|
作者
Xu, Jing [1 ]
Li, Pin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Endocrinol, Shanghai 200062, Peoples R China
关键词
Congenital adrenal hyperplasia; 21-hydroxylase deficiency; CYP21A2; Variants; GENOTYPE-PHENOTYPE CORRELATION; BRAZILIAN PATIENTS; GENE; MUTATIONS; DIAGNOSIS;
D O I
10.1016/j.clinbiochem.2019.04.008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: 21-hydroxylase deficiency (21-OHD) is the most common cause of congenital adrenal hyperplasia due to CYP21A2 gene mutation. The aim of study is to expand CYP21A2 mutational spectrum in the Chinese population and to provide novel genetic information in terms of ethnic diversity. Design and methods: 95 Chinese suspected 21-OHD patients with phenotypes varying from salt-wasting (SW) to nonclassic symptoms were recruited. The clinical characteristics were retrospectively analyzed. Sanger sequencing and multiplex ligation-dependent probe amplification were used to detect point mutations and large gene deletions, respectively. Results: 20 different mutant alleles were detected in 35 patients with 21-OHD. The most common variant was c.293-13A/C > G (30.0%), followed by p.I173N (20.0%), large gene conversions (14.3%), large gene deletions (11.4%), and p.R484Pfs*58 (4.3%). Remarkably, we identified a novel F450L variant, in silico predicted to be associated with the salt-wasting form. Two variants including p.R409C and p.R427H, previously considered as conserved in specific ethnicities due to a founder effect, were detected in our cohort. Further, a rare p.H63L + p.V70L variant, hitherto only observed in the Chinese population, in trans with different variants corresponding to the salt-wasting form resulted in diverse phenotypes. Conclusions: One novel and four rare variants of CYP21A2 gene corresponding to severe phenotypes were identified in our cohort. Two variants including p.R409C and p.R427H have wider ethnic distributions. Therefore, the sequence of CYP21A2 gene must be analyzed carefully in case rare or novel deleterious variants exist. Our findings improve the understanding of CYP21A2 mutational spectrum in 21-OHD patients and contribute to the precise diagnosis and prenatal counseling.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 50 条
  • [31] Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Hoepffner, W
    Herrmann, A
    Willgerodt, H
    Keller, E
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (05): : 705 - 711
  • [32] Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Tania Mayvel Espinosa Reyes
    Teresa Collazo Mesa
    Paulina Arasely Lantigua Cruz
    Adriana Agramonte Machado
    Emma Domínguez Alonso
    Henrik Falhammar
    [J]. BMC Endocrine Disorders, 20
  • [33] Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Espinosa Reyes, Tania Mayvel
    Collazo Mesa, Teresa
    Lantigua Cruz, Paulina Arasely
    Agramonte Machado, Adriana
    Dominguez Alonso, Emma
    Falhammar, Henrik
    [J]. BMC ENDOCRINE DISORDERS, 2020, 20 (01)
  • [34] Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Doerr, Helmuth G.
    [J]. HORMONE RESEARCH, 2007, 68 : 93 - 99
  • [35] Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency
    Ma, Dingyuan
    Chen, Yulin
    Sun, Yun
    Yang, Bing
    Cheng, Jian
    Huang, Meilian
    Zhang, Jin
    Zhang, Jingjing
    Hu, Ping
    Lin, Ying
    Jiang, Tao
    Xu, Zhengfeng
    [J]. CLINICAL BIOCHEMISTRY, 2014, 47 (06) : 455 - 463
  • [36] Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Bachelot, A.
    Chakhtoura, Z.
    Rouxel, A.
    Dulon, J.
    Touraine, P.
    [J]. ANNALES D ENDOCRINOLOGIE, 2007, 68 (04) : 274 - 280
  • [37] Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Theodoropoulou, M
    Barta, C
    Sasvari-Szekely, M
    Solyom, J
    Fekete, G
    Staub, M
    [J]. FASEB JOURNAL, 1997, 11 (09): : A1211 - A1211
  • [38] Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Merke, Deborah P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03): : 653 - 660
  • [39] Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Muessig, K.
    Kaltenbach, S.
    Maser-Gluth, C.
    Hartmann, M. F.
    Wudy, S. A.
    Horger, M.
    Gallwitz, B.
    Raue, F.
    Haering, H.-U.
    Schulze, E.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (04) : 208 - 214
  • [40] Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - the adult woman
    Hagenfeldt, KB
    [J]. GROWTH HORMONE & IGF RESEARCH, 2004, 14 : S67 - S71